Enoxaparin Sodium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Enoxaparin Sodium Price Trend, Index and Forecast
Track the latest insights on enoxaparin sodium price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Enoxaparin Sodium Prices Outlook Q3 2025
- Germany: USD 103240/KG
- China: USD 11140/KG
- Brazil: USD 135080/KG
- India: USD 25090/KG
- USA: USD 150800/KG
Enoxaparin Sodium Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the enoxaparin sodium prices in Germany reached 103240 USD/KG in September. The market experienced downward pressure as producers operated amid changes in the availability of upstream biochemical intermediates that influenced overall supply dynamics. Domestic manufacturers faced fluctuating operating rates due to variable production efficiencies and periodic constraints in sourcing key biological inputs.
During the third quarter of 2025, the enoxaparin sodium prices in China reached 11140 USD/KG in September. The market observed mild upward momentum as manufacturers benefited from steady output levels supported by consistent access to raw materials used in biochemical synthesis. Demand from domestic pharmaceutical companies remained adaptable as formulators adjusted procurement plans in response to evolving production schedules.
During the third quarter of 2025, the enoxaparin sodium prices in Brazil reached 135080 USD/KG in September. The market registered downward price movements influenced by variations in local manufacturing performance and inconsistencies in accessing essential biological inputs. Pharmaceutical buyers maintained cautious procurement strategies due to evolving production plans across hospitals and formulation facilities. Import-dependent supply chains experienced fluctuations in shipment timing and logistical processes, which affected availability patterns.
During the third quarter of 2025, the enoxaparin sodium prices in India reached 25090 USD/KG in September. The market was influenced by subdued demand from formulation units adjusting output levels in response to varying consumption trends across domestic healthcare channels. Suppliers managed production amid fluctuations in the availability of critical biochemical inputs, which shaped supply consistency. The presence of competitive local manufacturers contributed to restrained pricing as firms sought to maintain market share.
During the third quarter of 2025, the enoxaparin sodium prices in the USA reached 150800 USD/KG in September. Market sentiment softened as purchasing volumes from pharmaceutical manufacturers were influenced by adjustments in production planning across major formulation facilities. Supply conditions were shaped by operational variations at domestic plants handling biochemical synthesis. Import flows showed periodic fluctuations in availability, prompting buyers to reassess inventory strategies.
Enoxaparin Sodium Prices Outlook Q2 2025
- United States: USD 154000/KG
- Germany: USD 106000/KG
- China: USD 11000/KG
- Brazil: USD 141000/KG
- India: USD 26050/KG
During the second quarter of 2025, the enoxaparin sodium prices in the USA reached 154000 USD/KG in June. In the USA, enoxaparin sodium prices were shaped by demand from the pharmaceutical and healthcare sectors, particularly hospitals and clinics. Supply was influenced by imports of raw materials and active pharmaceutical ingredients, with shipping rates and customs procedures affecting landed costs. Domestic manufacturing faced high energy and labor expenses, while compliance with strict Food and Drug Administration regulations added quality assurance costs. Distribution through extensive healthcare networks also contributed to overall procurement expenses.
During the second quarter of 2025, enoxaparin sodium prices in Germany reached 106000 USD/KG in June. In Germany, enoxaparin sodium prices were influenced by consistent demand from the healthcare and pharmaceutical sectors. Production economics were impacted by raw material availability and energy tariffs in chemical manufacturing. Imports from other European Union countries and Asia supplemented supply, with freight charges and customs documentation shaping landed costs. Compliance with European Medicines Agency regulations increased testing and certification expenses, while labor and domestic logistics costs further added to distribution pressures across the healthcare system.
During the second quarter of 2025, the enoxaparin sodium prices in China reached 11000 USD/KG in June. In China, enoxaparin sodium prices were driven by demand from hospitals, pharmaceutical manufacturers, and research institutions. Domestic production was shaped by access to heparin raw materials, feedstock availability, and energy tariffs. Regulatory compliance and stricter environmental controls on chemical and pharmaceutical production increased operational costs. Export demand to North America and Europe affected domestic allocation, while port logistics, inland transport, and currency fluctuations against the US dollar contributed to supply chain expenses.
During the second quarter of 2025, the enoxaparin sodium prices in Brazil reached 141000 USD/KG in June. In Brazil, enoxaparin sodium prices were shaped by demand from public and private healthcare providers. The market relied significantly on imports of finished formulations and raw materials, making costs sensitive to global freight rates, port handling, and customs regulations. Currency volatility against the US dollar had a strong effect on procurement dynamics. Domestic logistics challenges, including long-haul trucking and infrastructure inefficiencies, added to distribution costs, while compliance with health regulatory standards increased certification expenses for suppliers.
During the second quarter of 2025, the enoxaparin sodium prices in India reached 26050 USD/KG in June. In India, enoxaparin sodium prices were influenced by demand from hospitals, pharmaceutical companies, and export markets. Production economics were shaped by access to raw materials, energy tariffs, and local labor costs. Exports to Europe and North America influenced domestic supply balances, with shipping costs and customs documentation adding to overall expenses. Compliance with regulatory frameworks, including Good Manufacturing Practices and international quality certifications, increased operational costs, while domestic logistics inefficiencies further added to supply chain expenses.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing enoxaparin sodium prices.
Europe Enoxaparin Sodium Price Trend
Q3 2025:
The Q3 enoxaparin sodium price index in Europe was shaped by evolving production dynamics among manufacturers balancing access to critical biochemical inputs with operating efficiency. Changing demand from regional pharmaceutical formulators influenced procurement cycles. Inventory management strategies were adjusted as buyers responded to fluctuating supply availability. Export-oriented producers navigated shifting trade flows across global markets, influencing supply distribution patterns. Overall sentiment reflected interactions between supply chain conditions and downstream consumption trends.
Q2 2025:
As per the enoxaparin sodium price index, European enoxaparin sodium prices were shaped by steady demand from hospitals, clinics, and pharmaceutical distributors. Supply relied on both domestic manufacturers and imports, with freight charges, customs compliance, and port handling shaping landed costs. Feedstock availability for heparin production influenced raw material expenses, while high energy tariffs and labor costs in pharmaceutical manufacturing hubs increased operational pressures. European Medicines Agency regulations required extensive testing, certification, and traceability, adding compliance-related costs. Distribution logistics across multiple countries within the region further contributed to overall procurement dynamics.
This analysis can be extended to include detailed enoxaparin sodium price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Enoxaparin Sodium Price Trend
Q3 2025:
The Q3 enoxaparin sodium price index in North America was influenced by shifts in supply availability across domestic and international channels. Pharmaceutical manufacturers adjusted production schedules as they navigated variable access to essential biological precursors. Distributors reassessed inventory strategies to maintain continuity across hospital networks. Demand patterns evolved as healthcare utilization rates shifted. Market competition among suppliers contributed to adjustments in pricing approaches.
Q2 2025:
As per the enoxaparin sodium price index, in North America, enoxaparin sodium prices were influenced by strong demand from the healthcare sector, particularly hospitals and large pharmacy networks. Supply was impacted by a mix of domestic production and imports, with shipping costs, port congestion, and customs clearance affecting landed expenses. Feedstock sourcing for heparin derivatives played a crucial role in production economics. Compliance with strict Food and Drug Administration regulations added quality assurance and certification costs. Additionally, inland transportation, warehousing, and labor availability shaped distribution and final procurement costs across healthcare providers.
Specific enoxaparin sodium historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Enoxaparin Sodium Price Trend
Q3 2025:
The report explores the enoxaparin sodium trends and enoxaparin sodium price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
Q2 2025:
As per the enoxaparin sodium price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
In addition to region-wise data, information on enoxaparin sodium prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Enoxaparin Sodium Price Trend
Q3 2025:
Asia Pacific’s Q3 pricing environment reflected steady production activities in key manufacturing hubs. Changes in the availability of upstream biochemical inputs shaped output consistency. Domestic demand patterns shifted as formulation units adjusted operations. Export flows varied across regional and global markets, influencing supplier strategies. These combined elements guided overall regional pricing trends.
Q2 2025:
In Asia Pacific, enoxaparin sodium prices were driven by demand from healthcare systems, pharmaceutical manufacturers, and export markets. China and India played leading roles in production, with costs influenced by access to raw materials, energy tariffs, and local labor availability. Export commitments to Europe and North America influenced domestic allocation, while logistics, including inland transport and port operations, shaped supply chain expenses. Regulatory compliance with international standards, including Good Manufacturing Practices and export certifications, further increased operational costs across regional producers.
This enoxaparin sodium price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Enoxaparin Sodium Price Trend
Q3 2025:
Q3 price trends in Latin America were influenced by supply chain adjustments as manufacturers navigated changes in access to imported biological components. Pharmaceutical buyers adopted flexible procurement strategies aligned with evolving production levels. Distribution channels managed inventories carefully amid varied shipment timings. Shifts in downstream demand further shaped pricing dynamics.
Q2 2025:
In Latin America, and particularly Brazil, enoxaparin sodium prices were influenced by demand from both public and private healthcare providers. Heavy reliance on imports made costs sensitive to international freight charges, customs requirements, and port handling. Currency volatility of the Brazilian real against the US dollar significantly impacted procurement expenses. Domestic logistics, including long-haul trucking and infrastructure inefficiencies, further increased distribution costs. Compliance with health regulatory standards for pharmaceutical imports added additional certification and testing expenses, shaping overall supply chain economics in the region.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Enoxaparin Sodium Pricing Report, Market Analysis, and News
IMARC's latest publication, “Enoxaparin Sodium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the enoxaparin sodium market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of enoxaparin sodium at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed enoxaparin sodium prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting enoxaparin sodium pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Enoxaparin Sodium Industry Analysis
The global enoxaparin sodium market size reached USD 4.60 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 10.24 Billion, at a projected CAGR of 9.30% during 2026-2034. The market is primarily driven by the expanding pharmaceutical manufacturing capacity, evolving treatment needs across healthcare systems, and steady demand for anticoagulant therapies. Increasing production optimization, changing procurement strategies, and evolving supply chain dynamics.
Latest developments in the enoxaparin sodium industry:
- January 2025: Enoxaparin sodium, a low molecular mass heparin used to treat thrombotic disorders and approved by the FDA, went on continued analytical refinement. A new study outlined a flame atomic absorption spectrophotometry method to quantify sodium content in the drug. Researchers reported strong precision and accuracy, noting a sodium level of 5.09 ppm, a correlation coefficient of 0.9978, a relative standard difference of 1.55% and a recovery rate of 100.8%, confirming compliance with USP standards.
Product Description
Enoxaparin Sodium is a low molecular weight heparin (LMWH) derived from unfractionated heparin. It functions primarily as an anticoagulant, preventing the formation of blood clots. It has a higher bioavailability and a longer half-life, permitting once or twice-daily dosing. It is essential in the prevention and management of thromboembolic disorders, which are associated with significant morbidity and mortality. It significantly reduces the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in postoperative patients, thus improving surgical outcomes. It enhances patient adherence and convenience, especially in outpatient settings where prolonged anticoagulation therapy might be required. It is used to prevent clotting in the dialysis circuit. It ensures the smooth operation of dialysis sessions and reduces the risk of clot-related complications. In pregnancy, Enoxaparin offers a safe and effective option for preventing and treating VTE. Its ability to prevent clot formation without crossing the placenta ensures that both maternal and fetal health are safeguarded.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Enoxaparin Sodium |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Enoxaparin Sodium Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of enoxaparin sodium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting enoxaparin sodium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The enoxaparin sodium price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.